Company: PTPI
Filing Date: 2025-04-11
Form Type: 8-K
Source: 0001104659-25-034283
Chunk: 2

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: 8-K
Item: Item 5.07
Chunk 2
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

On April 10, 2025, the Company held the Special Meeting. As of the
close of business on February 19, 2025, the record date for the Special Meeting, there were 29,929,668 shares of the Company’s Common
Stock issued and outstanding, with each share entitled to one vote, and 567.85 shares of Series A Convertible Preferred Stock, par value
$0.0001 per share (“ Preferred Stock”), issued and outstanding, with the Preferred Stock entitled to an aggregate of 252,374
votes, constituting all of the eligible securities entitled to vote on the proposals described below. Holders of the Company’s Common
Stock and Preferred Stock with a total aggregate voting power of 15,848,892 votes were present in person or represented by proxy at the
Special Meeting.

The matters described below were submitted to
a vote of the holders of the Company’s Common Stock and Preferred Stock at the Special Meeting. Each proposal is described in detail
in the Company’s Proxy Statement. All proposals were approved by the Company’s stockholders.

  Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of Common Stock underlying the Series A warrants (the “ Series A Warrants”) and Series B warrants (t...  

        For      Against      Abstain      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────
  4,531,733      723,510      113,054             2,980,595  

  Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which ...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

         For        Against      Abstain      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────
  14,593,543      1,001,281      254,068      -                 

  Approval of the Third Amendment to the Incentive Plan to increase the total number of shares of the Company’s Common Stock authorized for issuance under such plan by 1,000,000,000, to a total o...  

         For      Against      Abstain